Published in J Immunol on November 01, 1987
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci U S A (1998) 2.96
The glycosynapse. Proc Natl Acad Sci U S A (2002) 2.46
Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines. Nature (2007) 1.51
A lipid-specific toxin reveals heterogeneity of sphingomyelin-containing membranes. Biophys J (2004) 1.27
Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell. Bioorg Med Chem (2007) 1.22
Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj J (2001) 1.17
Conformation of the oligosaccharide chain of G(M1) ganglioside in a carbohydrate-enriched surface. Biophys J (1998) 0.98
Recent Development in Carbohydrate Based Anti-cancer Vaccines. J Carbohydr Chem (2012) 0.98
Human sperm carbohydrate antigens defined by an antisperm human monoclonal antibody derived from an infertile woman bearing antisperm antibodies in her serum. J Exp Med (1988) 0.96
Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J Clin Invest (1998) 0.95
Glycosphingolipids and cell death. Glycoconj J (2004) 0.95
Biosynthesis and functions of gangliosides: recent advances. Glycoconj J (1998) 0.89
Ganglioside biochemistry. ISRN Biochem (2012) 0.89
Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray. Proteomics Clin Appl (2010) 0.87
Synthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine Candidates. Medchemcomm (2011) 0.83
Differential distribution of major brain gangliosides in the adult mouse central nervous system. PLoS One (2013) 0.81
Molecular recognition of gangliosides and their potential for cancer immunotherapies. Front Immunol (2014) 0.80
Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches. Front Oncol (2013) 0.80
Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation. ACS Nano (2016) 0.78
Binding affinity of GM3 lactone for influenza virus. Glycoconj J (1999) 0.77
Antigenicity of the carbohydrate moiety of ganglioside GM3 having 3-O-acetyl ceramide. Glycoconj J (1999) 0.76
Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents. Front Oncol (2016) 0.76
Cultured cerebellar granule cells, but not astrocytes, produce an ester of ganglioside GD1b, presumably GD1b monolactone, from exogenous GD1b. Biochem J (1994) 0.75
Direct evidence that ganglioside is an integral component of the thyrotropin receptor. Proc Natl Acad Sci U S A (1991) 0.75
Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis: purification and characterization of the antigen. Am J Pathol (1989) 0.75
Human dendritic cell activation induced by a permannosylated dendron containing an antigenic GM3-lactone mimetic. Beilstein J Org Chem (2014) 0.75
A one pot synthesis of mono- and di-lactosyl sphingosines. Glycoconj J (2001) 0.75
Allylmalonamide as a bivalent linker: synthesis of biantennary GM3-saccharide--keyhole limpet hemocyanin glycoconjugate and the immune response in mice. Glycoconj J (1999) 0.75
Convergent synthesis of neoglycopeptides by coupling of 2-bromoethyl glycosides to cysteine and homocysteine residues in T cell stimulating peptides. Glycoconj J (1998) 0.75
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science (1997) 13.67
Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science (1997) 8.95
Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med (2000) 6.15
Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med (2000) 4.45
ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science (1990) 4.45
Molecular genetic basis of the histo-blood group ABO system. Nature (1990) 4.17
Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem (1981) 3.66
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med (2001) 3.56
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J Immunol (1998) 3.48
Properties of primed suppressor T cells and their products. Transplant Rev (1975) 3.42
Development of an MRI-compatible needle insertion manipulator for stereotactic neurosurgery. J Image Guid Surg (1995) 3.07
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci U S A (1998) 2.96
Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron (1997) 2.93
Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. J Immunol (1996) 2.83
Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J (1983) 2.80
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet (1998) 2.80
Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med (1995) 2.63
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol (1999) 2.58
Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med (1992) 2.52
Giant Rashba-type spin splitting in bulk BiTeI. Nat Mater (2011) 2.49
Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection. J Biol Chem (1993) 2.40
Homogenous junctional sequence of the V14+ T-cell antigen receptor alpha chain expanded in unprimed mice. Proc Natl Acad Sci U S A (1990) 2.38
Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol (1972) 2.37
An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J Clin Invest (1996) 2.35
CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci U S A (1991) 2.34
A role for mel-18, a Polycomb group-related vertebrate gene, during theanteroposterior specification of the axial skeleton. Development (1996) 2.33
alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci U S A (2000) 2.30
Antigen-specific suppressive factor produced by a transplantable I-J bearing T-cell hybridoma. Nature (1979) 2.28
Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med (2000) 2.25
Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression. Development (2001) 2.21
Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med (1997) 2.17
Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med (1977) 2.13
Properties of antigen-specific suppressive T cell factor in the regulation of antibody response of the mouse. II. In vitro activity and evidence for the I region gene product. J Immunol (1976) 2.12
Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. III. Dual gene control of the T-cell-mediated suppression of the antibody response. J Exp Med (1976) 2.12
New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem (1983) 2.08
Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood (1995) 2.04
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations. Int Immunol (1995) 2.02
Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line. J Exp Med (1978) 2.01
Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem (1986) 2.00
NKT cells are phenotypically and functionally diverse. Eur J Immunol (1999) 1.97
Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res (1985) 1.96
Structures and organization of cell surface glycolipids dependency on cell growth and malignant transformation. Biochim Biophys Acta (1975) 1.91
ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang (1989) 1.91
Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J Immunol (1999) 1.89
Studies on passive serum sickness. II. Factors determining the localization of antigen-antibody complexes in the murine renal glomerulus. Lab Invest (1978) 1.89
Extrathymic development of V alpha 14-positive T cells. J Exp Med (1993) 1.88
Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J Exp Med (1999) 1.88
Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells. J Biol Chem (1989) 1.88
Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry (2003) 1.86
Functional and molecular organisation of an antigen-specific suppressor factor from a T-cell hybridoma. Nature (1980) 1.84
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A (1999) 1.84
The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol (2000) 1.82
A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy. Am J Transplant (2009) 1.81
Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem (1984) 1.79
Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum (2001) 1.78
alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell Immunol (2000) 1.77
Changes in a surface-labelled galactoprotein and in glycolipid concentrations in cells transformed by a temperature-sensitive polyoma virus mutant. Nature (1974) 1.77
Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development (1997) 1.77
Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism, and their developmental change. Semin Hematol (1981) 1.76
Tumor-associated carbohydrate antigens. Annu Rev Immunol (1984) 1.76
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc Natl Acad Sci U S A (1999) 1.76
ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat Med (2001) 1.74
Presence of interchain disulfide bonds between two gene products that compose the secreted form of an antigen-specific suppressor factor. J Exp Med (1981) 1.73
Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. Clin Exp Allergy (2009) 1.71
Domain structure of human plasma fibronectin. Differences and similarities between human and hamster fibronectins. J Biol Chem (1983) 1.71
Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst (1983) 1.71
Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. J Nucl Med (2001) 1.71
Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer (1990) 1.70
Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J Biol Chem (1984) 1.70
Nitrogen-dependent accumulation of cytokinins in root and the translocation to leaf: implication of cytokinin species that induces gene expression of maize response regulator. Plant Cell Physiol (2001) 1.70
Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem (1998) 1.69
A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J Immunol (1999) 1.69
Genes encoding pseudo-response regulators: insight into His-to-Asp phosphorelay and circadian rhythm in Arabidopsis thaliana. Plant Cell Physiol (2000) 1.69
Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol (1995) 1.66
Compilation and characterization of Arabidopsis thaliana response regulators implicated in His-Asp phosphorelay signal transduction. Plant Cell Physiol (1999) 1.65
Regulation of homocytotropic antibody formation in the rat. II. Effect of X-irradiation. J Immunol (1971) 1.65
Dominant expression of a distinctive V14+ T-cell antigen receptor alpha chain in mice. Proc Natl Acad Sci U S A (1991) 1.63
A multivalent lacto-N-fucopentaose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective. J Exp Med (1984) 1.63
Expression of novel DNA-binding protein with zinc finger structure in various tumor cells. J Biol Chem (1990) 1.61
Regulation of homocytotropic antibody formation in the rat. 8. An antigen-specific T cell factor that regulates anti-hapten homocytotropic antibody response. J Immunol (1973) 1.61
Functional domain structure of fibronectin. Proc Natl Acad Sci U S A (1980) 1.59
Cell density-dependent changes of glycolipid concentrations in fibroblasts, and loss of this response in virus-transformed cells. Proc Natl Acad Sci U S A (1970) 1.59
Deficiency of c-kit+ cells in patients with a myopathic form of chronic idiopathic intestinal pseudo-obstruction. Am J Gastroenterol (1997) 1.58
The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol (2000) 1.57
Positive selection of invariant V alpha 14+ T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells. Proc Natl Acad Sci U S A (1995) 1.57
Newly identified genes involved in the signal transduction of Escherichia coli K-12. Gene (1994) 1.56
Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res (1999) 1.55
Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours. J Pathol (2001) 1.55
mel-18, a Polycomb group-related mammalian gene, encodes a transcriptional negative regulator with tumor suppressive activity. EMBO J (1995) 1.54
Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res (1988) 1.54
Superconducting coherence peak in the electronic excitations of a single-layer Bi2Sr1.6La0.4CuO6+delta cuprate superconductor. Phys Rev Lett (2008) 1.53
A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. J Biol Chem (1982) 1.53
NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol (2001) 1.52
Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. Proc Natl Acad Sci U S A (1992) 1.52
A new cell surface, detergent-insoluble glycoprotein matrix of human and hamster fibroblasts. The role of disulfide bonds in stabilization of the matrix. J Biol Chem (1981) 1.52
A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology (1998) 1.52
A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science (1983) 1.51